VAERS Explorer
Back to explore

Report #2829072

Received Mar 3, 2025

Hospitalized
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
60 yrs
State
—
Recovered
Not recovered
Vaccinated
Apr 1, 2024
Onset
Apr 1, 2024
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNKIM
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2UNK—

Symptoms (5)

Ankle fractureCardiac failure congestiveImmediate post-injection reactionIncomplete course of vaccinationMyocardial infarction

Symptom narrative

Heart attack; Congestive heart failure; Broken ankle; Inappropriate schedule of vaccine administered; This serious case was reported by a consumer via call center representative and described the occurrence of heart attack in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. In APR-2024, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, the patient did not receive the 2nd dose of Shingrix. In APR-2024, immediately after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced heart attack (Verbatim: Heart attack) (serious criteria hospitalization and GSK medically significant), congestive heart failure (Verbatim: Congestive heart failure) (serious criteria hospitalization and GSK medically significant) and ankle fracture (Verbatim: Broken ankle) (serious criteria hospitalization). On an unknown date, the patient experienced incomplete course of vaccination (Verbatim: Inappropriate schedule of vaccine administered). The outcome of the heart attack, congestive heart failure and ankle fracture were resolved with sequelae and the outcome of the incomplete course of vaccination was not applicable. It was unknown if the reporter considered the heart attack, congestive heart failure and ankle fracture to be related to Shingrix. The company considered the heart attack, congestive heart failure and ankle fracture to be unrelated to Shingrix and Shingrix. Additional Information: GSK Receipt Date: 24-FEB-2025 The reporter stated she received first dose of Shingrix vaccine in April 2024. She stated that shortly thereafter she had broken her ankle and was in the hospital with a heart attack and congestive heart failure. She was now recovered and ambulatory and wanted to get dose 2 of vaccine Till the time of reporting, the patient did not receive the second dose of Shingrix vaccine, which led to incomplete course of vaccination.; Sender's Comments: Myocardial infarction, Cardiac failure congestive and Ankle fracture are unlisted events which are considered unrelated to GSK vaccine Shingrix.